Ahmed El Gamal , DVM
About Ahmed El Gamal , DVM
Ahmed El Gamal, DVM, is a Regional Account Executive Payer at Bristol Myers Squibb with over 20 years of experience in the pharmaceutical industry, specializing in oncology and market access.
Current Role at Bristol Myers Squibb
Ahmed El Gamal is currently serving as the Regional Account Executive Payer, Specialty Pharmacy & Organized Customers for the U.S. Market at Bristol Myers Squibb. His role involves working with specialty pharmacies and organized customer segments to ensure effective market access strategies.
Previous Roles at Astellas Pharma
Ahmed worked at Astellas Pharma in various capacities, including Director of Market Access, Government Affairs, and Communications for the Middle East & Africa from 2019 to 2020. He also served as Associate Director of Commercial Operations for the Middle East, North Africa, and Sub-Saharan Africa in 2019 and was the Regional Oncology Marketing Lead for the same regions from 2017 to 2019.
Previous Roles at Bristol Myers Squibb
Before his current role, Ahmed held multiple positions at Bristol Myers Squibb. He was the Regional Marketing Lead for the Middle East, Africa, and India from 2015 to 2017, and Brand Manager Oncology for 5 Gulf Markets from 2013 to 2015. He also served as Product Manager Oncology for the U.S. Market from 2011 to 2013 and Associate Manager Marketing/Sales Operations for Oncology in the U.S. from 2008 to 2010. Ahmed’s earlier role at the company was as a Territory Business Manager for Cardiovascular in the U.S. from 2006 to 2007.
Education and Training
Ahmed El Gamal has a Doctor of Veterinary Medicine degree from Alexandria University. He furthered his education at Cornell University, where he studied Marketing Strategy and earned a Certificate. His academic background has provided a solid foundation for his extensive career in the pharmaceutical industry.
Experience in Pharmaceutical Industry
Ahmed El Gamal has over 20 years of experience in the pharmaceutical industry. His expertise spans both the U.S. market, where he has worked for 13 years, and emerging markets like the Middle East, Africa, and India, where he has spent over 7 years. He specializes in new launches and lifecycle management (LCM) for oncology brands, including targeted therapies and Immuno-Oncology (I-O).